The Cuban government created a state holding company that unites all biotechnology and pharmaceutical companies under one roof.
With decree 307/2012, the Council of Ministers approved the creation of BioCubaFarma, also known as Grupo de las Industrias BiotecnolÃ³gica y FaramcÃ©uticas.
BioFarmaCuba consists of 38 companies, including the commercial branches of all research institutions of the Scientific Pole in western Havana and all companies within the Grupo Empresarial Quimefa. The holding â€” run on “entrepreneurial principles,” according to the Granma daily â€” will be in charge of producing and selling medicine, equipment, high-tech health services, and exportable goods and services.
Pharmaceuticals are Cuba’s second-largest export product. Some of the better known products include a diabetic-foot drug, a pentavalent pediatric vaccine, and a lung cancer vaccine.
Carlos Manuel GutiÃ©rrez Calzado was appointed president of the holding. Previously, the trained physician and member of the communist party’s Central Committee was director of the National Center of Scientific Research.
JosÃ© Miguel Miyar Barrueco, the high-profile chief of the Scientific Pole, was assigned to “other tasks directly with” RaÃºl Castro, Granma said.